Advanced search
Publication Cover
Pharmaceutical Biology Volume 59, 2021 - Issue 1
Submit an article Journal homepage
3,202
Views
6
CrossRef citations to date
0
Altmetric
Review Article

Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis

Chuihua Suna Department of Critical Care Medicine, Weifang People’s Hospital, Weifang, China
,
Fang Dongb Infection Control Office, Weifang People’s Hospital, Weifang, China
,
Ting Xiaoc Department of Infectious Diseases, Weifang People’s Hospital, Weifang, China
&
Wenni Gaod Dispensing Room for Intravenous Transfusion, Weifang People's Hospital, Weifang, ChinaCorrespondence[email protected]
Pages 470-481 | Received 31 Oct 2020, Accepted 06 Apr 2021, Published online: 27 Apr 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.